Beurs gesloten -
OTC Markets
22:00:00 26-04-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
10,53
USD
|
+5,30%
|
|
+0,77%
|
-5,98%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
195,8
|
176,6
|
232,4
|
439,7
|
393,3
|
372,4
|
-
|
-
|
Bedrijfswaarde
1 |
195,8
|
176,6
|
232,4
|
439,7
|
393,3
|
372,4
|
372,4
|
372,4
|
K/w-verhouding
|
778
x
|
-52,8
x
|
-12,5
x
|
-28,9
x
|
-14,9
x
|
-32,7
x
|
17,7
x
|
5,98
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
3,83
x
|
3,61
x
|
3,21
x
|
4,96
x
|
3,02
x
|
2,02
x
|
1,48
x
|
1,23
x
|
Bedrijfswaarde/omzet
|
3,83
x
|
3,61
x
|
3,21
x
|
4,96
x
|
3,02
x
|
2,02
x
|
1,48
x
|
1,23
x
|
Bedrijfswaarde/EBITDA
|
42,7
x
|
30,9
x
|
11,9
x
|
33,8
x
|
14
x
|
9,94
x
|
5,01
x
|
3,05
x
|
Bedrijfswaarde/FCF
|
-
|
-
|
70,5
x
|
-
|
-
|
44,3
x
|
11,3
x
|
-
|
FCF Yield
|
-
|
-
|
1,42%
|
-
|
-
|
2,26%
|
8,86%
|
-
|
Price to Book
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Aantal aandelen (in duizenden)
|
25.173
|
25.746
|
26.903
|
29.790
|
35.118
|
35.363
|
-
|
-
|
Referentieprijs
2 |
7,780
|
6,860
|
8,640
|
14,76
|
11,20
|
10,53
|
10,53
|
10,53
|
Datum van publicatie
|
13/03/20
|
8/03/21
|
10/03/22
|
23/03/23
|
19/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
51,16
|
48,87
|
72,48
|
88,6
|
130,2
|
184,8
|
251,3
|
303
|
EBITDA
1 |
4,583
|
5,715
|
19,5
|
13,02
|
28,12
|
37,47
|
74,26
|
121,9
|
Bedrijfsresultaat (EBIT)
1 |
-4,803
|
0,385
|
1,614
|
1,919
|
0,431
|
7,452
|
44,13
|
93,55
|
Operationele Marge
|
-9,39%
|
0,79%
|
2,23%
|
2,17%
|
0,33%
|
4,03%
|
17,56%
|
30,88%
|
Resultaat voor belastingen (EBT)
1 |
-0,125
|
-3,415
|
-17,87
|
-14,01
|
-23,71
|
-12,32
|
27,66
|
83,12
|
Nettowinst (verlies)
1 |
0,168
|
-3,357
|
-18,48
|
-14,09
|
-24,41
|
-11,97
|
22,99
|
78,14
|
Nettomarge
|
0,33%
|
-6,87%
|
-25,5%
|
-15,9%
|
-18,75%
|
-6,48%
|
9,15%
|
25,79%
|
WPA
2 |
0,0100
|
-0,1300
|
-0,6900
|
-0,5100
|
-0,7500
|
-0,3225
|
0,5933
|
1,760
|
Free Cash Flow
1 |
-
|
-
|
3,296
|
-
|
-
|
8,4
|
33
|
-
|
FCF-marge
|
-
|
-
|
4,55%
|
-
|
-
|
4,55%
|
13,13%
|
-
|
Kasstroomconversie (ebitda)
|
-
|
-
|
16,91%
|
-
|
-
|
22,42%
|
44,44%
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
143,53%
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
13/03/20
|
8/03/21
|
10/03/22
|
23/03/23
|
19/03/24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Omzet
1 |
18,71
|
20,19
|
22,12
|
23,32
|
22,82
|
20,33
|
26,1
|
33,47
|
34,26
|
36,36
|
37,27
|
43,2
|
48,36
|
55,93
|
56,6
|
EBITDA
1 |
4,922
|
4,599
|
4,94
|
4,505
|
-1,021
|
1,089
|
5,342
|
11
|
9,209
|
2,563
|
3,864
|
7,786
|
11,28
|
14,5
|
14,43
|
Bedrijfsresultaat (EBIT)
1 |
-3,717
|
-1,755
|
2,101
|
1,69
|
-0,094
|
-1,778
|
1,21
|
2,352
|
1,744
|
-4,875
|
-2,43
|
0,0055
|
3,603
|
6,272
|
6,925
|
Operationele Marge
|
-19,87%
|
-8,69%
|
9,5%
|
7,25%
|
-0,41%
|
-8,75%
|
4,64%
|
7,03%
|
5,09%
|
-13,41%
|
-6,52%
|
0,01%
|
7,45%
|
11,21%
|
12,23%
|
Resultaat voor belastingen (EBT)
1 |
-8,328
|
-7,285
|
-2,438
|
-6,199
|
-6,429
|
1,055
|
-6,931
|
-4,244
|
-2,852
|
-9,683
|
-7,418
|
-5,232
|
-1,701
|
2,005
|
2,185
|
Nettowinst (verlies)
1 |
-8,328
|
-7,418
|
-2,438
|
-6,239
|
-6,464
|
1,055
|
-6,643
|
-4,229
|
-4,391
|
-9,148
|
-7,288
|
-4,892
|
-1,71
|
1,87
|
1,69
|
Nettomarge
|
-44,51%
|
-36,74%
|
-11,02%
|
-26,75%
|
-28,32%
|
5,19%
|
-25,45%
|
-12,64%
|
-12,81%
|
-25,16%
|
-19,56%
|
-11,33%
|
-3,54%
|
3,34%
|
2,99%
|
WPA
2 |
-0,3100
|
-0,2700
|
-0,0900
|
-0,2300
|
-0,2400
|
0,0400
|
-0,2200
|
-0,1400
|
-0,1300
|
-0,2600
|
-0,2000
|
-0,1375
|
-0,0450
|
0,0475
|
0,0450
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
9/11/21
|
10/03/22
|
5/05/22
|
9/08/22
|
14/11/22
|
23/03/23
|
11/05/23
|
9/08/23
|
13/11/23
|
19/03/24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
3,3
|
-
|
-
|
8,4
|
33
|
-
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Totale activa
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettoactief per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Cashflow per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
-
|
1,79
|
2,6
|
-
|
0,9
|
0,77
|
-
|
Capex/omzet
|
-
|
-
|
2,46%
|
2,93%
|
-
|
0,49%
|
0,31%
|
-
|
Datum van publicatie
|
13/03/20
|
8/03/21
|
10/03/22
|
23/03/23
|
19/03/24
|
-
|
-
|
-
|
Laatste slotkoers
10,53
USD Gemiddelde koersdoel
26,65
USD Spread / Gemiddelde doel +153,09% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| -5,98% | 372 mln. | | +25,83% | 661 mld. | | +27,00% | 566 mld. | | -6,76% | 352 mld. | | +20,34% | 332 mld. | | +3,00% | 283 mld. | | +13,09% | 231 mld. | | +5,46% | 200 mld. | | -9,61% | 195 mld. | | -6,26% | 145 mld. |
Farmaceutische producten - Andere
|